Baxter Announces New AVIVA Line Of Intravenous Solutions
Wed, 19 Apr 2006 06:00 AM EST
... Baxter HealthcareCorporation announced today that it has recently received approval from theU.S. Food and Drug Administration (FDA) on its new AVIVA premium line ofintravenous solutions and plans to begin a limited launch of the new linein the second half of 2006. While providing similar functionality and benefits of the company'sVIAFLEX flexible container systems, AVIVA containers are made of non-PVC(non-polyvinyl chloride) film, contain no latex and offer a DEHP-free [di(2-ethylhexyl) phthalate-free] fluid pathway to patients... click link for more info. ...
Related Topics
- Cardiovascular Health
- Body Solutions
- Minocycline Injection
- Conjugated Estrogens Injection
- Cytomegalovirus Immune Globulin Intravenous Injection
- Drotrecogin alfa
- Sumatriptan Oral
- Chelation therapy
- Ethacrynic Acid
- Temazepam
- Zoledronic Acid for Injection
- Dantrolene
- Immune Globulin Intravenous Injection
- Immune Globulin Intramuscular Injection
- Fluorouracil
- Orphenadrine
- Allopurinol
- Glimepiride
- Lisinopril and Hydrochlorothiazide
- Cefprozil

Not Signed In -


